Problems and Countermeasures to Improve Clinical Trial Participants’Compensation Rights in China  

作　　者：Yang Xiuqiao Wen Ping Lin Hong Chen Wenhuan Chen Yuwen 

机构地区：[1]Department of Clinical Trail Management,Shenzhen Maternity&Child Healthcare Hospital,Shenzhen 518028,China [2]School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China [3]Jincheng Tongda&Neal,Shenzhen 518000,China

出　　处：《Asian Journal of Social Pharmacy》2024年第1期58-63,共6页亚洲社会药学（英文）

基　　金：Liaoning Pharmaceutical Industry Innovation and Development Strategy Research and Funding Project(2020lslktyb-095);National Medical Products Administration-Special Fund of Drug Regulatory Research Institute of Shenyang Pharmaceutical University(2021jgkx004);Shenzhen Maternity&Child Healthcare Hospital Science Foundation(2022(73));Shenzhen Health Economics Society Research Fund Project(202333).

摘　　要：Objective To discuss the problems existing in the compensation of Chinese clinical trial participants and propose some suggestions for improving their rights.Methods The literature related to the participants’right to compensation at home and abroad was searched to study the inadequacy of the compensation right for clinical trial participants in China from four aspects:insurance system,principle of attribution,legal relationship and compensation regulations.Then,some suggestions to improve the participants’right to compensation were proposed.Results and Conclusion China lacks clear legal norms for participants’right to compensation.There are problems such as unclear insurance rules and compensation rules,unclear contractual relationships between parties to clinical trials,and no laws and regulations to rely on for attribution and compensation.China should issue regulatory guidelines related to the right to compensation of participants in clinical trials,so that all parties in clinical trials can have rules to follow if there is the occurrence of injury,which can better protect the rights and interests of the participants.

关 键 词：clinical trial PARTICIPANT compensation right 

分 类 号：R951[医药卫生—药学]